Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Leica Biosystems News & Events

A new PD-L1 BOND-Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need

Published:
NEWCASTLE, ENGLAND, UK NOVEMBER 2018 – Leica Biosystems, a leading provider of pathology products and solutions, globally launched a new PD-L1 antibody for use on their fully automated BOND IHC and ISH staining platform. The new PD-L1 (programmed...

Unlocking the complexities of cancer biology with BOND RX and Ultivue.

Published:
Melbourne, Australia and Cambridge, Massachusetts – September 14, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated multiplexing in under 6 hours. Building on its legacy of...

Partnership of Leeds Teaching Hospitals NHS Trust with Leica Biosystems Achieves Major Milestone for Cancer Diagnostics

Published:
Collaboration to enable large-scale transition from glass slides to digital images for pathology diagnoses across all subspecialties VISTA, Calif.—Oct. 11, 2018— Leica Biosystems the cancer diagnostics leader achieved a major digital pathology...

For Breast Biopsies, MammoPort Standardizes Tissue Transfer from Radiology to Pathology to Ensure Quality and Reduce Errors

Published:
New from Leica Biosystems, first integrated specimen containment and transport system promises to enhance efficiency and diagnostic confidence. RICHMOND, Ill.— October 2, 2018 — Leica Biosystems, the leader in cancer diagnostics from biopsy to...

For High-Volume Pathology Labs, HistoCore SPECTRA Workstation Delivers Immediately Dry Slides atFaster TurnaroundTimes

Published:
Integrating revolutionary technology from Leica Biosystems offers exceptionally high throughput and consistent staining quality to enhance efficiency and diagnostic confidence. NUSSLOCH, GERMANY, 10 SEPTEMBER, 2018. Leica Biosystems, the cancer...

LEICA BIOSYSTEMS APERIO LV1 IVD APPROVED FOR REMOTE FROZEN SECTION AND TELEPATHOLOGY*

Published:
VISTA, CA – July 31st, 2018 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that its live view telepathology system, the Aperio LV1 IVD, can now be used for on-screen diagnosis in Europe**, Canada, Australia and...

INSPIRING INNOVATION, LEICA BIOSYSTEMS INTRODUCES THE NEXT-GEN BOND RX IHC, ISH AND EMERGING TESTS STAINER

Published:
Melbourne, Australia – June 18, 2018 - Simplify your research in cancer biology and discover new approaches to diagnosis with the new BOND RX next generation research stainer by Leica Biosystems. The BOND RX system provides researchers with the...

Rotary Microtome Solutions Provide Pathology Labs High Quality Sectioning and Enhanced User Safety

Published:
Nussloch, Germany,30 May2018. Leica Biosystems announcesthe addition of a new family of Rotary Microtomes to its full line of histology equipment and consumables. The line-up includes the HistoCore BIOCUT, HistoCore MULTICUT and HistoCoreAUTOCUT...

"Antibodies to Artificial Intelligence" for Pathologists, Researchers and IT

Published:
Description Today, both Industry and Academia are heavily investing in Artificial Intelligence (AI). Machine learning has already proven that it is possible to train computers to try and emulate the performance of humans. AI is currently deployed in...

Multiplex Immunofluorescence Profiling of Tumor Biopsies Using UltraPlex mxIF Technology

Published:
Register Now for On Demand Abstract: An unmet need in tissue diagnostics is the ability to simultaneously detect three or more markers on a single tissue specimen, i.e. multiplexing. Unlike other immunoassays, i.e. flow cytometry, ELISA and bead...